Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

FuboTV Has Surface Relevance, But Is That Enough?

By Josh Enomoto, InvestorPlace Contributor

On the surface, FUBO stock is a compelling play on the streaming revolution. However, the details are a bit more problematic.

8 Cheap Stocks to Buy With Your Next Stimulus Check

By Josh Enomoto, InvestorPlace Contributor

With the government hopefully set to issue another round of stimulus checks, here are eight cheap stocks to consider.

10 Stocks Under $10 to Buy Before They Soar

By Josh Enomoto, InvestorPlace Contributor

One of the counterintuitive dynamics of the pandemic-disrupted year in 2020 was the rise of Wall Street. But that doesn’t mean you’ve missed the boat, as these stocks under $10 demonstrate.

Experience Investment Is a Cynically Profitable Investment in the New Normal

By Josh Enomoto, InvestorPlace Contributor

At first glance, the underlying urban air mobility service of EXPC stock seems a bit much during this health and economic crisis. But the finer details suggest a contrarian play at work.

Is It Time For Hexo Stock To Get Stoked Again?

By Josh Enomoto, InvestorPlace Contributor

Though a troubled name, HEXO stock has added some positivity to its investment profile thanks to its high-potential CBD beverage venture.

Opendoor Stock Is a Speculative Name

By Josh Enomoto, InvestorPlace Contributor

Thanks to its iBuying innovations, Opendoor stock has benefitted from delivering next-generation solutions. But will that be enough?

9 Stocks Selling at a Discount Right Now

By Josh Enomoto, InvestorPlace Contributor

One of the surprising developments of 2020 was the tremendous rise of the equities market. However, there are still undervalued opportunities to be had with these stocks selling at a discount.

Pfizer Faces a New Perception Risk You Shouldn’t Ignore

By Josh Enomoto, InvestorPlace Contributor

Pfizer stock was earlier a key benefactor from the coronavirus vaccine race, but a new perceptional risk is weighing on shares.

Don’t Let SPAC Hype Detract You From Churchill Capital Corp IV

By Josh Enomoto, InvestorPlace Contributor

Forget the rumor mill surrounding CCIV stock; the real story is how Lucid Motors is making all the right business decisions.

Hyliion Holdings Isn’t a Comforting Play But That’s Not the Whole Story

By Josh Enomoto, InvestorPlace Contributor

On multiple levels, including the weak economy and rising competitive threats, HYLN stock doesn’t make sense. However, if you don’t mind volatility, Hyliion offers short-term upside potential.

Load More